Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial is a research paper published in EClinicalMedicine (2021). On theSindex it has a DataRank of 2.3. It has been cited 92 times, with 63 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.680
From this paper's citation signal
Citation Network Contribution
1.6
From 45 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 63 citers.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Grant: R01HD083292
DSM
Grant: 15/991,735
DSM
Grant: 2646554
National Institutes of Health
Grant: 1R01HD083292-01A1
Docosahexaenoic Acid (DHA) Supplementation in Pregnancy to Reduce Early Preterm Birth
University of Cincinnati
FWCI
6.93
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals